Pharmaceutical companies lobbied to 'water down' rules on Covid vaccine access

Pharmaceutical companies lobbied to 'water down' rules on Covid vaccine access

India and Brazil led calls for a waiver on intellectual properties to potentially give poorer countries better vaccine access but the EU, including Ireland, took a firm stance against the Trips Waiver. 

Lobbying from pharmaceutical companies to European officials led to the “watering down” of a radical proposal on vaccine access, an investigation by Politico and the Bureau of Investigative Journalism has found.

India and Brazil led calls for a waiver on intellectual properties to potentially give poorer countries better vaccine access. Although supported by America, the European Union, including Ireland, took a firm stance against the Trips Waiver. 

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited